Key statistics dashboard for PAVmed Inc. (PAVM). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay.
Stock Data
| Price | $3.92 |
| Market Cap | $25M |
| Enterprise Value | $38.3M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.24 |
| Price / Book | 0.70 |
| P/S | 223.41 |
| EV/EBITDA | -2.34 |
| EV/Sales | 342.02 |
| EV/FCF | -0.01 |
| P/FCF | -0.01 |
| Earnings Yield | -49.19% |
| FCF Yield | -10491.45% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -254.46% |
| EBIT Margin | -14653.57% |
| EBITDA Margin | -14600.00% |
| Operating Margin | -23842.86% |
| Net Margin | -10794.64% |
| Return on Equity | -33.51% |
| Return on Assets | -30.06% |
| Return on Invested Capital | -72.77% |
| Return on Capital Employed | -73.92% |
Financial Health
| Current Ratio | 1.19 |
| Quick Ratio | 1.19 |
| Cash Ratio | 0.93 |
| Debt / Equity | 0.49 |
| Debt / Assets | 42.44% |
| Net Debt / EBITDA | -0.81 |
| Interest Coverage | -1483.56 |
Per-Share Data
| Revenue per share | 0.02 |
| Book Value per share | 3.08 |
| Cash per share | 0.60 |
| FCF per share | -418.72 |
| Tangible Book Value per share | 3.08 |
| Dividend per share | 0.00 |
Related companies: ADVB · APVO · BMRA · BNR · DHAI · HSCS · IINN
Explore sector: Healthcare · Medical - Devices
More sections of PAVM: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks